Biomarker-driven development of new therapies for autoimmune diseases: current status and future promises.

Laurence Laigle Loubna Chadli Philippe Moingeon

Published in: Expert review of clinical immunology (2023)

The integration by AI-powered analytics of massive data provided by multi-omics technologies, high-resolution medical imaging and sensors borne by patients will eventually allow the identification of clinically relevant BMKs, likely in the form of combinatorial predictive algorithms, to support future drug development for autoimmune diseases.

Keyphrases

high resolution
end stage renal disease
big data
ejection fraction
machine learning
newly diagnosed
chronic kidney disease
healthcare
artificial intelligence
prognostic factors
peritoneal dialysis
mass spectrometry
deep learning
single cell
patient reported
photodynamic therapy
patient reported outcomes
high speed